Literature DB >> 31347155

Network analysis of prospective brain development in youth with benign epilepsy with centrotemporal spikes and its relationship to cognition.

Camille Garcia-Ramos1, Kevin Dabbs2, Jack J Lin3, Jana E Jones2, Carl E Stafstrom4, David A Hsu2, Mary Elizabeth Meyerand5, Vivek Prabhakaran1,6, Bruce P Hermann2.   

Abstract

OBJECTIVE: Benign epilepsy with centrotemporal spikes (BECTS) is the most common childhood idiopathic localization-related epilepsy syndrome. BECTS presents normal routine magnetic resonance imaging (MRI); however, quantitative analytic techniques have captured subtle cortical and subcortical magnetic resonance anomalies. Network science, including graph theory (GT) analyses, facilitates understanding of brain covariance patterns, potentially informing in important ways how this common self-limiting epilepsy syndrome may impact normal patterns of brain and cognitive development.
METHODS: GT analyses examined the developmental covariance among cortical and subcortical regions in children with new/recent onset BECTS (n = 19) and typically developing healthy controls (n = 22) who underwent high-resolution MRI and cognitive assessment at baseline and 2 years later. Global (transitivity, global efficiency, and modularity index [Q]) and regional measures (local efficiency and hubs) were investigated to characterize network development in each group. Associations between baseline-based GT measures and cognition at both time points addressed the implications of GT analyses for cognition and prospective cognitive development. Furthermore, an individual contribution measure was investigated, reflecting how important for cognition it is for BECTS to resemble the correlation matrices of controls.
RESULTS: Groups exhibited similar Q and overall network configuration, with BECTS presenting significantly higher transitivity and both global and local efficiency. Furthermore, both groups presented a similar number of hubs, with BECTS showing a higher number in temporal lobe regions compared to controls. The investigated measures were negatively associated with 2-year cognitive outcomes in BECTS. SIGNIFICANCE: Children with BECTS present a higher-than-normal global developmental configuration compared to controls, along with divergence from normality in terms of regional configuration. Baseline GT measures demonstrate potential as a cognitive biomarker to predict cognitive outcome in BECTS 2 years after diagnosis. Similarities and differences in developmental network configurations and their implications for cognition and behavior across common epilepsy syndromes are of theoretical interest and clinical relevance. Wiley Periodicals, Inc.
© 2019 International League Against Epilepsy.

Entities:  

Keywords:  Rolandic epilepsy; benign epilepsy with centrotemporal spikes; brain volume development; cognition; graph theory

Mesh:

Year:  2019        PMID: 31347155     DOI: 10.1111/epi.16290

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

1.  Connectome-based prediction of brain age in Rolandic epilepsy: a protocol for a multicenter cross-sectional study.

Authors:  Fuqin Wang; Yu Yin; Yang Yang; Ting Liang; Tingting Huang; Cheng He; Jie Hu; Jingjing Zhang; Yanli Yang; Qianlu Xing; Tijiang Zhang; Heng Liu
Journal:  Ann Transl Med       Date:  2021-03

2.  Network phenotypes and their clinical significance in temporal lobe epilepsy using machine learning applications to morphological and functional graph theory metrics.

Authors:  Camille Garcia-Ramos; Veena Nair; Rama Maganti; Jedidiah Mathis; Lisa L Conant; Vivek Prabhakaran; Jeffrey R Binder; Beth Meyerand; Bruce Hermann; Aaron F Struck
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

3.  The relationship between epilepsy and cognitive function in benign childhood epilepsy with centrotemporal spikes.

Authors:  Yihan Li; Yulei Sun; Tingting Zhang; Qi Shi; Jintao Sun; Jing Xiang; Qiqi Chen; Zheng Hu; Xiaoshan Wang
Journal:  Brain Behav       Date:  2020-09-22       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.